A cytokine-mediated link between innate immunity, inflammation, and cancer

被引:1515
作者
Lin, Wan-Wan
Karin, Michael
机构
[1] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
[3] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan
关键词
D O I
10.1172/JCI31537
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.
引用
收藏
页码:1175 / 1183
页数:9
相关论文
共 125 条
[1]   Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I that highly express IL-6 receptor α myeloma cells [J].
Abroun, S ;
Ishikawa, H ;
Tsuyama, N ;
Liu, SQ ;
Li, FJ ;
Otsuyama, K ;
Zheng, X ;
Obata, M ;
Kawano, MM .
BLOOD, 2004, 103 (06) :2291-2298
[2]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[3]  
Alas S, 2001, CLIN CANCER RES, V7, P709
[4]   Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy [J].
Almasan, A ;
Ashkenazi, A .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (3-4) :337-348
[5]   The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions [J].
Apte, Ron N. ;
Dotan, Shahar ;
Elkabets, Moshe ;
White, Malka R. ;
Reich, Eli ;
Carmi, Yaron ;
Song, Xiaping ;
Dvozkin, Tatyana ;
Krelin, Yakov ;
Voronov, Elena .
CANCER AND METASTASIS REVIEWS, 2006, 25 (03) :387-408
[6]   Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development [J].
Arnott, CH ;
Scott, KA ;
Moore, RJ ;
Robinson, SC ;
Thompson, RG ;
Balkwill, FR .
ONCOGENE, 2004, 23 (10) :1902-1910
[7]   Smoldering and polarized inflammation in the initiation and promotion of malignant disease [J].
Balkwill, F ;
Charles, KA ;
Mantovani, A .
CANCER CELL, 2005, 7 (03) :211-217
[8]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[9]   TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
[10]   TGF-beta as a T cell regulator in colitis and colon cancer [J].
Becker, C ;
Fantini, MC ;
Neurath, MF .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (1-2) :97-106